SCHEMBL25910302

SCHEMBL25910302

CC(C)Nc1ncc(-c2ccc3cc(Oc4ccnc(C(F)F)c4)ccc3n2)c(=O)n1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 6/20 0.51
▸ PDGFRA P16234 4/20 0.51
▸ PDGFRB P09619 3/20 0.51
▸ LCK P06239 2/20 0.51
▸ KIT P10721 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ FLT3 P36888 1/20 0.51
▸ PTK6 Q13882 1/20 0.51
▸ KDR P35968 2/20 0.36
▸ SCN9A Q15858 7/20 0.35
▸ AURKA O14965 1/20 0.33
▸ RPS6KA5 O75582 1/20 0.33
▸ MET P08581 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ HGF P14210 1/20 0.33
▸ RPS6KB1 P23443 1/20 0.33
▸ MAPK9 P45984 1/20 0.33
▸ TEK Q02763 1/20 0.33
▸ MST1R Q04912 1/20 0.33
▸ BTK Q06187 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25911790 0.87 CSF1R (0.53) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910028 0.87 CSF1R (0.53) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25913293 0.86 CSF1R (0.52) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25912060 0.85 CSF1R (0.51) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910026 0.84 CSF1R (0.50) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910683 0.84 CSF1R (0.56) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25911894 0.84 CSF1R (0.51) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910568 0.83 CSF1R (0.55) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25909917 0.83 PDGFRB (0.52) CSF1RPDGFRAPDGFRBLCKKIT
SCHEMBL25910037 0.83 CSF1R (0.50) CSF1RPDGFRAPDGFRBLCKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback